The Prodrug Opportunity: Making Good Drugs Better
Elegance in Chemistry, Product Development, and Marketability
- INFOGRAPHIC: Spotlight on How a Discovery Program Was Born
Looking at the CAR-T Landscape As First Approval Nears
Sounds of Science Podcast
Literature Review: Organs-On-Chips Marching In
This Article Discusses a Robust Regulator of G Protein Signaling (RGS) Inhibitor Discovery and Characterization Paradigm
- Dolomite Microfluidics
- Unit 1, Anglian Business Park
- Orchard Rd.
- Royston , SG8 5TW
- UNITED KINGDOM
Dolomite has its roots in Syrris, which was founded in 2001 by Mark Gilligan and Richard Gray to address the challenges faced by the pharmaceutical industry. While Syrris focuses on flow chemistry and microreactors, Dolomite was set up as a subsidiary to provide microfluidic solutions to customers around the world in a very wide range of applications outside the field of research chemistry.